Edition:
United Kingdom

Bellicum Pharmaceuticals Inc (BLCM.OQ)

BLCM.OQ on NASDAQ Stock Exchange Global Market

6.60USD
16 Feb 2018
Change (% chg)

$0.63 (+10.55%)
Prev Close
$5.97
Open
$6.09
Day's High
$6.62
Day's Low
$6.05
Volume
268,529
Avg. Vol
160,806
52-wk High
$15.51
52-wk Low
$5.02

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.13 -0.706
Jun '17 0.00 -0.739
Mar '17 0.13 -0.805
FY 2016 Dec '16 0.08 -0.737
Sep '16 0.11 -0.657
Jun '16 0.10 -0.613
Mar '16 0.09 -0.561
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 4 0.06 0.13 0.00 2.00
Quarter Ending Jun-18 4 0.06 0.13 0.00 2.00
Year Ending Dec-18 6 0.54 1.81 0.00 68.83
Earnings (per share)
Quarter Ending Mar-18 5 -0.74 -0.68 -0.80 -0.36
Quarter Ending Jun-18 5 -0.71 -0.61 -0.84 -0.36
Year Ending Dec-18 7 -2.93 -2.55 -3.37 -1.90
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 83.93 32.90
P/E High - Last 5 Yrs. -- 292.71 45.97
P/E Low - Last 5 Yrs. -- 91.44 24.37
Beta -- 0.90 0.89
Price to Sales (TTM) 1,169.61 110.72 5.77
Price to Book (MRQ) 3.08 13.56 5.41
Price to Tangible Book (MRQ) 3.08 14.02 6.98
Price to Cash Flow (TTM) -- 71.33 23.42
% Owned Institutions 57.02 12.89 2.22

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.66 5.21
Payout Ratio(TTM) -- 15.70 43.72

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -100.00 398.33 9.24
Sales (TTM) vs TTM 1 Yr. Ago 13.73 78.63 5.59
Sales - 5 Yr. Growth Rate -- 32.11 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago -20.53 25.10 19.65
EPS (TTM) vs TTM 1 Yr. Ago -26.74 -- --
EPS - 5 Yr. Growth Rate -- 38.95 10.73
Capital Spending - 5 Yr. Growth Rate -- 40.24 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.18
Current Ratio (MRQ) 8.34 5.30 2.97
LT Debt to Equity (MRQ) 22.22 22.82 12.22
Total Debt to Equity (MRQ) 25.02 24.47 16.52
Interest Coverage (TTM) -- -98.78 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.03 54.70
Gross Margin - 5 Yr. Avg. -- 51.06 52.42
EBITD Margin (TTM) -24,512.38 -- --
EBITD - 5 Yr. Avg -- -572.68 10.86
Operating Margin (TTM) -25,442.11 -717.10 4.64
Operating Margin - 5 Yr. Avg. -- -594.00 6.26
Pre-Tax Margin (TTM) -26,033.13 -691.66 5.44
Pre-Tax Margin - 5 Yr. Avg. -- -597.35 6.60
Net Profit Margin (TTM) -26,033.13 -692.88 1.76
Net Profit Margin - 5 Yr. Avg. -- -600.21 2.91
Effective Tax Rate (TTM) -- 22.57 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.19 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 2,936 22,602,121 855,667,832
Net Income/Employee (TTM) -764,427 2,968,747 100,655,557
Receivable Turnover (TTM) 0.98 20.14 5.78
Inventory Turnover (TTM) -- 2.36 3.35
Asset Turnover (TTM) 0.00 0.39 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -52.94 -1.05 10.98
Return on Assets - 5 Yr. Avg. -- -0.57 12.37
Return on Investment (TTM) -56.99 1.66 14.43
Return on Investment - 5 Yr. Avg. -- 2.23 16.18
Return on Equity (TTM) -67.22 2.58 16.13
Return on Equity - 5 Yr. Avg. -- 3.13 17.47
  1 Year 3 Year 5 Year
Sales % 37.59 -41.53 --
EPS (TTM) % -39.43 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Bellicum Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 13.25 9.34 99 53
13 Week -2.82 -7.55 89 62
26 Week -6.65 -13.75 88 77
52 Week -43.96 -52.50 38 50
YTD -16.52 -26.69 56 56
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 56.51%
# of Holders: 143
Total Shares Held: 18,791,648
3 Mo. Net Change: -21,075
# New Positions: 19
# Closed Positions: 12
# Increased Positions: 52
# Reduced Positions: 55
# Net Buyers: -3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.